The 2026 Healthtech Messaging Index
AcuityMD
acuitymd.com·scored August 23, 2026
26/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push AcuityMD into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for MedTech sales intelligence and commercial operations platform, it named:
Buyer we put in the prompt: VP of Sales, Sales Operations Leader, or Commercial Operations Director at a medical device or MedTech company. Both the buyer and the category were inferred from AcuityMD’s homepage alone. The model had no web access.
AcuityMD was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "MedTech sales intelligence and commercial operations platform", and described you accurately: "AcuityMD is a MedTech-focused sales intelligence platform that helps medical device commercial teams identify and prioritize target physicians and accounts based on procedure volume and claims data.". Your positioning is landing with the machines.
Overall assessment
AcuityMD's biggest strength is its vertical specificity and social proof: the MedTech-only focus, role-segmented value props, and hard customer metrics (97% forecast accuracy, $300K+ pipeline uncovered) give it genuine distinctiveness. The biggest gap is rebellion and owned language ... the page has no named enemy, no coined category term, and no mechanism behind AcuityAI, leaving it feeling like a strong brochure rather than a point-of-view company that AI engines will quote as authoritative.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
12Alternatives Acknowledged
“No mention of competitors, alternative solutions, or 'do nothing' framing anywhere on the page.”
The page never acknowledges competitors, alternative tools, or the cost of the status quo as a deliberate choice ... alternatives are completely absent.
All 19 signals, scored 0 to 2.
Total 26/38
Narrative Clarity
8 signals
- 2
01The 7-Second Test
“Built for MedTech. Trusted by 500+ medical device companies." / "The MedTech intelligence platform.”
Within 7 seconds, a visitor knows the vertical (MedTech), the audience (medical device commercial teams), and the product category (intelligence platform); vertical specificity makes the who and what immediately clear.
- 1
02Rebellion / Movement
“The problem is, you don't have accurate, usable data, which leaves you feeling frustrated, and your sales goals at risk.”
The page names a problem (bad data) but never names a named enemy, a competitor, or a movement against a specific industry status quo ... it's a complaint, not a rebellion.
- 1
03Owned Language & Category
“The MedTech intelligence platform." / "AcuityAI" / "MedTech intelligence platform”
The page repeats 'MedTech intelligence platform' and coins 'AcuityAI' but never defines or owns the category frame in a way AI could quote as a distinct, named concept ... it's a description, not a claimed category.
- 2
04ICP Clarity
“For sales leaders" / "For sales reps" / "For commercial operations" / "For marketers" / "For national accounts”
Five explicit role headers ... sales leaders, sales reps, commercial ops, marketers, national accounts ... all scoped to MedTech, making ICP identification immediate and specific.
- 1
05Problem Leadership
“The problem is, you don't have accurate, usable data, which leaves you feeling frustrated, and your sales goals at risk.”
The problem statement appears mid-page rather than leading the hero, and the hero opens with solution positioning ('The MedTech intelligence platform'), not buyer pain.
- 2
06Solution Clarity
“Move faster on your best opportunities with every team aligned ... now powered by AcuityAI.”
Combined with the hero label 'The MedTech intelligence platform,' a visitor can repeat in one sentence what AcuityMD does: it's an AI-powered intelligence platform that aligns MedTech commercial teams around their best opportunities.
- 1
07Cost of Inaction
“you don't have accurate, usable data, which leaves you feeling frustrated, and your sales goals at risk.”
The cost of inaction is vaguely named ('sales goals at risk') but never quantified or made visceral ... no lost revenue figures, missed quotas, or competitive loss rates tied to inaction.
- 1
08Promised Land
“Smarter outreach, faster sales, and more life-changing technology to patients who need it.”
The promised land is gestured at but remains generic; no specific after-state is painted with concrete metrics or a vivid day-in-the-life that a buyer can see themselves living in.
Trust Signal
4 signals
- 2
09Proof & Evidence
“97% forecast accuracy" / "$300K+ pipeline uncovered" / "10x faster onboarding" / "3x faster sales process”
Multiple customer sections deliver hard, specific numbers with named companies and deltas, not just adjectives, satisfying the concrete outcome requirement.
- 2
10Social Proof
“Our executives use AcuityMD every single week - it's become the foundation of how we run the business." ... Route 92 Medical”
Named customer logos, verbatim testimonials attributed to named companies, and linked case studies across six customers provide layered, credible social proof.
- 1
11Authority & Credibility
“AcuityMD was built by former MedTech professionals to accelerate how commercial teams identify opportunities”
Founder/team credentials are claimed in one line without names, titles, or specific backgrounds; there are no frameworks, original research citations beyond the one report, or external authority signals.
- 0
12Alternatives Acknowledgedweakest
“No mention of competitors, alternative solutions, or 'do nothing' framing anywhere on the page.”
The page never acknowledges competitors, alternative tools, or the cost of the status quo as a deliberate choice ... alternatives are completely absent.
AI Signal
6 signals
- 2
13Customer Focus
“Commercial teams across MedTech...use AcuityMD to accelerate product adoption, grow revenue, and scale more efficiently.”
The page consistently centers customer outcomes ... reps winning faster, executives forecasting with confidence, teams scaling ... rather than feature catalogs about the company itself.
- 1
14AI-Parmesan Index
“Move faster on your best opportunities with every team aligned ... now powered by AcuityAI." / "AI-powered insights to help close them.”
AcuityAI is named and one research stat is cited ('AI users are 3x more likely to hit quota'), but the mechanism of how AcuityAI works is never explained, making it feel like AI-sprinkling with minimal substance.
- 1
15LLM Quotability
“MedTech companies create life-changing technology every day. Getting it in the hands of the right physicians is critical.”
Some lines are punchy enough to quote, but most declarative sentences are too vague or generic to be citation-ready recommendations an LLM would lift to distinguish this company.
- 1
16Copyright Freshness
“New research: AI users are 3x more likely to hit quota. Download the AI Adoption in MedTech Sales report”
One recent research report is referenced at the top, but no visible copyright year, no dated case studies or blog posts visible in the scraped content signal recency to AI crawlers.
- 2
17Entity Distinctiveness
“Built for MedTech. Trusted by 500+ medical device companies." + vertical-specific roles, procedure-level data, ASC rollouts, contract compliance”
The combination of MedTech-only vertical focus, procedure-volume data at physician level, and specific use cases (ASC rollout, referral paths, contract compliance) makes this unmistakably distinct from generic sales intelligence tools.
- 2
18AI Recommendation Check
“AI described you as: "AcuityMD is a MedTech-focused sales intelligence platform that helps medical device commercial teams identify and prioritize target physicians and accounts based on procedure volume and claims data.”
AI named you when asked who it recommends for "MedTech sales intelligence and commercial operations platform", and described you accurately: "AcuityMD is a MedTech-focused sales intelligence platform that helps medical device commercial teams identify and prioritize target physicians and accounts based on procedure volume and claims data.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“1. Build your strategy 2. Uncover insights 3. Win more business" / "[Request a demo]”
A numbered three-step path exists and a 'Request a demo' CTA is present, but there is no visible soft secondary CTA working alongside it, so the full connected system of primary + secondary is incomplete.
Keep the lead
AI already names AcuityMD. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing AcuityMD the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.